Daejeon, South Korea

Woo-Il Kim

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sovargen Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Woo-Il Kim. Retrieved from https://idiyas.com/inventor/woo-il-kim-yojl16fp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Woo-Il Kim in Epilepsy Treatment

Introduction

Woo-Il Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of intractable epilepsy. His innovative approach focuses on utilizing mTOR inhibitors to provide therapeutic solutions for patients suffering from this challenging condition.

Latest Patents

Woo-Il Kim holds a patent for a composition aimed at the prevention or treatment of intractable epilepsy. This patent specifically addresses the use of mTOR inhibitors for the prophylaxis, amelioration, or therapy of conditions such as Focal Cortical Dysplasia (FCD). His work in this area represents a promising advancement in epilepsy treatment.

Career Highlights

Throughout his career, Woo-Il Kim has been associated with prominent organizations, including Sovargen Co., Ltd. and the Korea Advanced Institute of Science and Technology. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Woo-Il Kim has collaborated with esteemed colleagues, including Jeong Ho Lee and Jae Seok Lim. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work in the field of epilepsy treatment.

Conclusion

In summary, Woo-Il Kim's contributions to the treatment of intractable epilepsy through his innovative use of mTOR inhibitors highlight his role as a significant inventor in the medical field. His work continues to inspire advancements in therapeutic solutions for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…